Senzime AB Valuation
| SEZI Stock | SEK 5.84 0.01 0.17% |
At this time, the company appears to be overvalued. Senzime AB has a current Real Value of kr5.14 per share. The regular price of the company is kr5.84. Our model measures the value of Senzime AB from inspecting the company fundamentals such as Return On Equity of -0.64, shares owned by insiders of 43.52 %, and Current Valuation of 771.13 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Senzime AB's price fluctuation is slightly risky at this time. Calculation of the real value of Senzime AB is based on 3 months time horizon. Increasing Senzime AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Senzime AB's intrinsic value may or may not be the same as its current market price of 5.84, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.84 | Real 5.14 | Hype 5.84 | Naive 6.11 |
The intrinsic value of Senzime AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Senzime AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Senzime AB helps investors to forecast how Senzime stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Senzime AB more accurately as focusing exclusively on Senzime AB's fundamentals will not take into account other important factors: Senzime AB Total Value Analysis
Senzime AB is at this time anticipated to have takeover price of 771.13 M with market capitalization of 531.12 M, debt of 617 K, and cash on hands of 74.87 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Senzime AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
771.13 M | 531.12 M | 617 K | 74.87 M |
Senzime AB Investor Information
About 44.0% of the company outstanding shares are owned by corporate insiders. The book value of Senzime AB was at this time reported as 3.75. The company recorded a loss per share of 1.37. Senzime AB had not issued any dividends in recent years. The entity had 585:574 split on the 9th of March 2017. Based on the measurements of operating efficiency obtained from Senzime AB's historical financial statements, Senzime AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Senzime AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Senzime AB has an asset utilization ratio of 6.29 percent. This implies that the Company is making kr0.0629 for each dollar of assets. An increasing asset utilization means that Senzime AB is more efficient with each dollar of assets it utilizes for everyday operations.Senzime AB Ownership Allocation
Senzime AB shows a total of 69.88 Million outstanding shares. Senzime AB maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Senzime AB Profitability Analysis
The company reported the revenue of 10.98 M. Net Loss for the year was (82.14 M) with loss before overhead, payroll, taxes, and interest of (4.39 M).About Senzime AB Valuation
The stock valuation mechanism determines Senzime AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Senzime AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Senzime AB. We calculate exposure to Senzime AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Senzime AB's related companies.Senzime AB develops patient-oriented monitoring systems that assess patients biochemical and physiological processes before, during and after surgery in Sweden. Senzime AB was founded in 1997 and is based in Uppsala, Sweden. Senzime AB is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Senzime AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Senzime AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Senzime AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Senzime AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Senzime AB's revenue streams: Identify Senzime AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Senzime AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Senzime AB's growth potential: Evaluate Senzime AB's management, business model, and growth potential.
- Determine Senzime AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Senzime AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Senzime Stock Analysis
When running Senzime AB's price analysis, check to measure Senzime AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senzime AB is operating at the current time. Most of Senzime AB's value examination focuses on studying past and present price action to predict the probability of Senzime AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senzime AB's price. Additionally, you may evaluate how the addition of Senzime AB to your portfolios can decrease your overall portfolio volatility.